==== Front Ann Saudi MedAnn Saudi MedAnnals of Saudi Medicine0256-49470975-4466King Faisal Specialist Hospital and Research Centre 10.5144/0256-4947.2008.142asm-2-142LettersCA-125: a marker for diagnosis and follow-up of pleuroperitoneal and lymph node tuberculosis Wani Abdul Majid Akhtar Mubeena Department of Medicine, Hera General Hospital, Makkah, Saudi ArabiaCorrespondence and reprints: Abdul Majid Wani, Department of Medicine, Hera General Hospital, Makkah 10513, Saudi Arabia, dr_wani_majid@yahoo.co.inMar-Apr 2008 28 2 142 143 Copyright © 2008, Annals of Saudi Medicine2008This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. ==== Body To the Editor: We present a case of pleuroperitoneal and lymph node tuberculosis (TB) whose clinical, radiological, and laboratory data could have been easily mistaken for advanced ovarian carcinoma, and then subjected to unnecessary laparotomy and surgical resections with severe consequences. Our case, a 45-year-old female, had ascites, extensive lymph adenopathy, bilateral ovarian cysts, and pleural effusion (Figures 1, 2). Biopsy of an accessible cervical lymph node revealed caseous lymphadenitis (Figure 3). With antitubercular treatment, CA-125 levels of 531 mIU/L declined to 36 mIU/L in parallel with clinical and radiological improvement (Figure 4). CA-125 is a glycoprotein of high molecular weight, which is detected by the monoclonal antibody OC125, first described by Bast et al in 1981.1 CA-125 is elevated in a variety of malignant and benign conditions,2,3 but its main clinical application is limited to diagnosis and follow-up of ovarian cancer in which only 50% of stage 1 but 80% to 85% of advanced stages have elevated CA-125.4 The titer has been used to differentiate between benign and malignant conditions,5 but very high levels (>1000 mIU/L) have been reported in benign conditions such as massive pleural effusion, ascites, and chronic liver disease.6 Elevation of CA-125 in peritoneal tuberculosis (TB) has been reported and misinterpreted as disseminated ovarian malignancy. 7 A decline of CA-125 with antitubercular drug therapy has paralleled clinical improvement, and has been advocated as a marker in the follow-up of response to treatment. 8,9 Although false positivity with CA-125 is high and specificity and sensitivity are poor,10 elevated levels in a clinical setting of ovarian carcinoma must be taken with caution to avoid unnecessary laparotomies and even extensive surgical resection of pelvic masses.11,12 Thus, it is evident from our case that not only can an elevated CA-125 level be useful in considering the presence of a non-malignant condition like TB, especially in our part of the world, but can also be used as a marker for response to treatment and an indicator of the activity of a disease like TB.11 Figure 1 Abdominal CT scan showing ascites. Figure 2 CT scan showing tuberculous pleural effusion before treatment. Figure 3 Low-power photomicrograph showing tubercular lymphadenitis. Figure 4 CT scan showing resolved ascites after treatment. ==== Refs REFERENCES 1 Bast RC Feeney M Lazarus H Nadler LM Colvin RC Knapp RC Reactivity of a monoclonal antibody with human ovarian carcinoma J Clin Invest 1981 68 1331 7 7028788 2 Tingulstad S Hagen B Skjeldestad FE Onsrud M Kiserud T Halvorsen T Nustad K Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the pre-operative diagnosis of pelvic masses Br J Obstet Gynaecol 1996 103 826 31 8760716 3 Meden H Fattahi-Meibodi A CA125 in benign gynecological conditions Int J Biol Markers 1998 13 231 7 10228907 4 Duffy MJ Bornberer JM Kulpa J CA125 in ovarian cancer. European group on tumor markers (EGTM) guideline for clinical use Int J Gynecoloncol 2005 [AUTHOR: Complete authors and volume and page nos.] 5 Le Thi Huong D Mohattane H Piette JC Bogdan A Auzeby A Touitou Y Godeau P Specificity of CA-125 tumor marker. A study of 328 cases of internal medicine Presse Med 1988 Article in French 3 17 2287 91 2463618 6 Hussain SF Grayez J Grigorian A Green JT Massive pleural effusion and marked increase of CA125 Postgrad Med J 2004 80 300 1 15138325 7 Straugon JM Robertson MW Partridge EE A patient with a pelvic mass, elevated CA-125 and fever Gynecol Oncol 2000 77 471 2 10831363 8 Mansour M Linden ER Colby S Posner G Marsh F Jr Elevation of carcinoembryonic antigen and CA-125 in a patient with multivisceral tuberculosis J Natl Med Assoc 1997 89 142 3 9046768 9 Thakur V Mukerjee U Kumar K Elevated serum cancer antigen levels in advanced abdominal tuberculosis Med Oncol 2001 18 289 91 11918456 10 Lantheaume S Soler S Issartel B Isch JF Lacassin F Rougier Y Tabaste JL Peritoneal tuberculosis simulating advanced ovarian carcinoma: a case report Gynecol Obstet Fertil 2003 31 624 6 Article in French 14563607 11 Yilmaz A Ece F Bayramgürler B Akkaya E Baran R The value of CA-125 in the evaluation of tuberculosis activity Respir Med 2001 95 666 9 11530955 12 Piura B Rabinovich A Leron E Yanai-Inbar I Mazor M Peritoneal tuberculosis-an uncommon disease that may deceive the gynecologist Eur J Obestet Gynecol Reprod Biol 2003 110 2 230 4